Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells
- PMID: 14764541
- DOI: 10.1182/blood-2003-04-1011
Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells
Abstract
Kostmann syndrome, or severe congenital neutropenia (SCN), is an autosomal recessive disorder of neutrophil production. To investigate the potential role of apoptosis in SCN, bone marrow aspirates and biopsies were obtained from 4 patients belonging to the kindred originally described by Kostmann and 1 patient with SCN of unknown inheritance. An elevated degree of apoptosis was observed in the bone marrow of these patients, and a selective decrease in B-cell lymphoma-2 (Bcl-2) expression was seen in myeloid progenitor cells. Furthermore, in vitro apoptosis of bone marrow-derived Kostmann progenitor cells was increased, and mitochondrial release of cytochrome c was detected in CD34(+) and CD33(+) progenitors from patients, but not in controls. Administration of granulocyte colony-stimulating factor (G-CSF) restored Bcl-2 expression and improved survival of myeloid progenitor cells. In addition, cytochrome c release was partially reversed upon incubation of progenitor cells with G-CSF. In sum, these studies establish a role for mitochondria-dependent apoptosis in the pathogenesis of Kostmann syndrome and yield a tentative explanation for the beneficial effect of growth factor administration in these patients.
Similar articles
-
Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors.Blood. 2000 Jan 1;95(1):320-7. Blood. 2000. PMID: 10607719
-
Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia.Blood. 2001 Jan 1;97(1):147-53. doi: 10.1182/blood.v97.1.147. Blood. 2001. Retraction in: Blood. 2014 Aug 7;124(6):983. doi: 10.1182/blood-2014-07-586784. PMID: 11133754 Retracted.
-
Heterogeneous expression pattern of pro- and anti-apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor.Br J Haematol. 2005 Apr;129(2):275-8. doi: 10.1111/j.1365-2141.2005.05428.x. Br J Haematol. 2005. PMID: 15813856
-
Kostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropenia.Acta Paediatr. 2007 Jun;96(6):813-9. doi: 10.1111/j.1651-2227.2007.00274.x. Acta Paediatr. 2007. PMID: 17537008 Review.
-
Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations.Pediatr Blood Cancer. 2014 Jun;61(6):1041-8. doi: 10.1002/pbc.24964. Epub 2014 Jan 30. Pediatr Blood Cancer. 2014. PMID: 24482108 Review.
Cited by
-
Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.Med Oncol. 2008;25(4):374-9. doi: 10.1007/s12032-008-9049-z. Epub 2008 Feb 16. Med Oncol. 2008. PMID: 18278570
-
A JAGN1-associated severe congenital neutropenia zebrafish model revealed an altered G-CSFR signaling and UPR activation.Blood Adv. 2024 Aug 13;8(15):4050-4065. doi: 10.1182/bloodadvances.2023011656. Blood Adv. 2024. PMID: 38739706 Free PMC article.
-
Primary immunodeficiency diseases associated with neurologic manifestations.J Clin Immunol. 2012 Feb;32(1):1-24. doi: 10.1007/s10875-011-9593-8. Epub 2011 Oct 26. J Clin Immunol. 2012. PMID: 22038677 Review.
-
Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cells.Br J Haematol. 2021 Jan;192(1):200-211. doi: 10.1111/bjh.17137. Epub 2020 Nov 18. Br J Haematol. 2021. PMID: 33206996 Free PMC article.
-
A zebrafish model for HAX1-associated congenital neutropenia.Haematologica. 2021 May 1;106(5):1311-1320. doi: 10.3324/haematol.2019.240200. Haematologica. 2021. PMID: 32327498 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources